53 related articles for article (PubMed ID: 6603293)
1. Serum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases.
Yang C; Li N; Wang Y; Zhang P; Zhu Q; Li F; Han Q; Lv Y; Yu L; Wei P; Liu Z
J Interferon Cytokine Res; 2014 Oct; 34(10):787-94. PubMed ID: 24811691
[TBL] [Abstract][Full Text] [Related]
2. Increased serum IgE concentrations during infection and graft versus host disease after bone marrow transplantation.
Walker SA; Rogers TR; Perry D; Hobbs JR; Riches PG
J Clin Pathol; 1984 Apr; 37(4):460-2. PubMed ID: 6368605
[TBL] [Abstract][Full Text] [Related]
3. Immunological studies in patients with HBsAg-positive chronic active hepatitis--spontaneous lymphocyte transformation and natural killer cell activity.
Koo JY; Park BC; Chung JM
Korean J Intern Med; 1987 Jul; 2(2):221-6. PubMed ID: 3154834
[TBL] [Abstract][Full Text] [Related]
4. Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.
Wada T; Arima T; Nagashima H
Gastroenterol Jpn; 1987 Jun; 22(3):312-21. PubMed ID: 3040509
[TBL] [Abstract][Full Text] [Related]
5. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
6. The active T rosette: an early marker for T-cell activation.
Wybran J; Dupont E
Ann Immunol (Paris); 1982; 133D(2):211-8. PubMed ID: 6219610
[TBL] [Abstract][Full Text] [Related]
7. Diminished active T rosette levels and increased spontaneous B lymphocyte blastogenesis in hepatitis B virus positive chronic active hepatitis.
Budillon G; Scala G; D'Onofrio C; Cassano S; De Ritis F
Clin Exp Immunol; 1983 Jun; 52(3):472-6. PubMed ID: 6603293
[TBL] [Abstract][Full Text] [Related]
8. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I. Lymphocyte subpopulations.
Ponzetto A; Arrigoni A
G Batteriol Virol Immunol; 1979; 72(1-6):28-32. PubMed ID: 317950
[TBL] [Abstract][Full Text] [Related]
9. T and B lymphocytes in patients with chronic active hepatitis (CAH).
Colombo M; Vernace SJ; Paronetto F
Clin Exp Immunol; 1977 Oct; 30(1):4-9. PubMed ID: 304778
[TBL] [Abstract][Full Text] [Related]
10. Active rosette-forming lymphocytes in chronic hepatitis.
Stanciu L; Urcan S; Părău N; Radu D; Popescu S
Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551
[TBL] [Abstract][Full Text] [Related]
11. Autologous rosette-forming T cells and their relationship to OKT4+ and OKT8+ cells in chronic HBV infection.
Victorino RM; Lucas M; de Moura MC
J Clin Lab Immunol; 1986 Jul; 20(3):137-41. PubMed ID: 2943900
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immunity in acute and chronic hepatitis.
Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
[TBL] [Abstract][Full Text] [Related]
13. Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.
Hotta R; Kuriki J; Kakumu S
Clin Exp Immunol; 1981 Nov; 46(2):375-81. PubMed ID: 6461458
[TBL] [Abstract][Full Text] [Related]
14. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.
Chisari FV; Bieber MS; Josepho CA; Xavier C; Anderson DS
J Immunol; 1981 Jan; 126(1):45-9. PubMed ID: 6450241
[TBL] [Abstract][Full Text] [Related]
15. Characterization of glass adherent human mononuclear cells.
Koller CA; King GW; Hurtubise PE; Sagone AL; LoBuglio AF
J Immunol; 1973 Nov; 111(5):1610-2. PubMed ID: 4583079
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
